Drug Profile
Research programme: type 2 diabetes mellitus therapeutic - Camurus
Alternative Names: CAM 2036Latest Information Update: 04 May 2016
Price :
$50
*
At a glance
- Originator Camurus
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 04 May 2016 Discontinued - Preclinical for Type-2 diabetes mellitus in Sweden (unspecified route)
- 01 Jan 2014 Preclinical trials in Type-2 diabetes mellitus in Sweden (unspecified route)